IAHF LIST:
See the press release below my comments by Orphan Medical which has just succeeded in stealing GHB away from the consuming public.
On February 1, 2000 the so called "Hillary J. Farias Date Rape Prevention Act of 1999" was passed in the House by a vote of 339-2, proving once again that members of Congress are very easily led by the nose, and that they don't examine the facts of issues such as this but simply act out of political expediency with no concern for the truth, not even bothering to check whether or not Hillary Farias was ever even raped (she wasn't), and whether or not GHB even played any role in her death (she clearly never even ingested it.)
I spoke with Sergio Oliveira, President of Body International, and a Constitutional Challenge is being prepared to address this scam, because GHB is a metabolite of GABA, and is unquestionably a dietary supplement under DSHEA. You can support this constitutional challenge by purchasing Body International Magazine on your newstand or by calling 877-687-9637 for a subscription. Since Clinton hasn't yet signed the new so called "law" you can stock up on GHB via http://www.ravenrest.com/ til the so called "law" goes into effect.
Hillary Farias was never raped, but the dietary consuming public sure has been in her name, (with nary a whimper of protest from NNFA, which has clearly become an arm of the FDA). Hilary Farias died from congenital heart disease, which runs in her family. Two months after her death the police persuaded a second medical examiner to test the body for presence of GHB, which did appear in her blood at 27 mg/l as a natural breakdown product of bodily decomposition-but it had never even been ingested prior to death.
So now Orphan Medical will sell GHB as "Xyrem" to people with sleep disorders, and the consuming public will have to pay through the nose for what should be an inexpensive, widely available product. You'll be considered a "felon" if you possess GHB (except by prescription), and the charges for possessing it (except as "Xyrem") will be as severe as if you'd been caught with cocaine or heroin. Nice little scam, eh? This is as absurd as the ban on DHEA is in Canada where it is a felony to possess. "Safety" is not the issue here, "PROFITS" and using slick PR as a means of conning Congress clearly is the name of the game and we're all the losers for it.
Whats _NEXT_ NNFA/FDA/Orphan Medical? DHEA? Pregnenalone? Kava? Niacin? Valerian? Vitamin C?
DO NOT LAUGH! In Norway they used undercover cops to chase down anyone suspected of selling high potency vitamin C! We're moving in that direction, because NNFA has clearly sold out to help protect the interests of Orphan Medical - and we can expect no loyalty from them on ANYTHING as evidenced by their endorsement of the pharmaceutically funded, totally unscientific National Academy of Science paper titled "A Risk Assessment Model for Establishing Upper Levels for Nutrients" which the FDA illegally put on the table at CODEX in order to grease the skids, to boost the vitamin proposal past outraged consumers world wide!!!
Orphan Medical Press Release Follows:
Congressional Bill Supporting the Continued Development of Medically Formulated GHB Moves to the President
Updated 4:51 PM ET February 1, 2000
MINNEAPOLIS, Feb. 1 /PRNewswire/ --
The U.S. House of Representatives approved by a vote of 339-2 federal legislation making gamma hydroxybutyrate (GHB) illegal while allowing medical formulations to be available for clinical testing and potential medical use.
The bill was sent to the President and will become law with his signature. Orphan Medical, Inc. is evaluating Xyrem(R) (sodium oxybate) oral solution, a medically formulated GHB, in the treatment of narcolepsy, a chronic and debilitating sleep disorder.
The bill directs the U.S. Attorney General to use her emergency scheduling authority to make illicitly made GHB a Schedule I substance within 60 days. Schedule I is the designation by which illegal drugs such as heroin are controlled.
The bill also says the Attorney General's order must treat medically-formulated GHB products, such as Orphan Medical's Xyrem, as a Schedule III substance which will allow for continued research and development.
Orphan Medical recently reported results of clinical trials in which Xyrem was assessed as a treatment for narcolepsy, and particularly the symptom of cataplexy. Cataplexy is a loss of muscle control that occurs in response to strong emotional reactions such as laughter, anger, or surprise and can cause a person to fall or collapse during waking hours. The condition occurs in up to 60-75% of an estimated 125,000 patients with narcolepsy, and is currently treated with anti-depressants, selective serotonin uptake inhibitors, and tricyclic antidepressants. Long-term treatment with these REM suppressing compounds may be limited by efficacy, tolerance and adverse side effects such as dry mouth, weight gain, tachycardia and loss of libido.
John Bullion, CEO of Orphan Medical said, "We believe that Orphan Medical's recently reported Xyrem clinical trials results strongly indicate that Xyrem may be an important treatment for narcolepsy. Cataplexy is poorly treated by current therapies and Xyrem represents a potential effective long- term treatment for this chronic disease. We plan to submit an NDA for Xyrem to the FDA later this year, and expect that it will be granted a priority review. If the FDA approves Xyrem, it will be an important new drug for the treatment of narcolepsy. This bill gives law enforcement officials the tools they need to punish those who use GHB illicitly and to commit crimes, while protecting patient access to a promising new drug."
Abbey Meyers, President of the National Organization of Rare Disorders, said, "This legislation recognizes the critical need of patients with this rare disorder and does not preclude the scientific and clinical assessment of GHB for medical therapy. Much more attention needs to be directed toward the development of drugs for rare disorders. This bill recognizes the valid medical use of a drug for a seriously ill population of patients that have been neglected by medicine until now."
Bob Cloud, President of Narcolepsy Network, commented, "This appears to be an important treatment for narcolepsy. I'm aware of many patients enrolled in Orphan Medical's clinical trials who, prior to receiving Xyrem, could not function on a daily basis, and now, with Xyrem, can hold jobs, drive, and perform functions that most of us take for granted. This legislation provides hope to all narcolepsy patients that Xyrem's potential as a treatment for narcolepsy or its symptoms will not be eliminated by irresponsible use of GHB."
Orphan Medical, Inc. is dedicated to patients with inadequately treated and uncommon diseases. To that end, the acquires, develops, and markets products of high medical value for patients within selected strategic therapeutic market segments. Orphan Medical's Internet Web Site address is http://www.orphan.com/
The information in this press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. A number of factors could cause actual results to differ materially from the Company's assumptions and expectations. These are set forth in the cautionary statements included in Exhibit 99 to Orphan Medical's most recent Form 10-Q or Form 10-K filed with the Securities and Exchange Commission. All forward-looking statements are qualified by, and should be considered in conjunction with, such cautionary statements.
Contact: John Howell Bullion of Orphan Medical, Inc., 612-513-6900
**************************************************************
IAHF:(International Advocates for Health Freedom) PO Box 625 Floyd, Virginia,24091, USA 800-333-2553, overseas: 540-745-6534, 540-745-6535 fax, http://www.iahf.com email: jham@iahf.com
Help Get a Codex Oversight Hearing:
Call Beth Clay at 202-225-5074
House Government Reform and Oversight Committee- See Codex Oversight Section of IAHF website for more info.
If You Belong to NNFA- Ask Them Why They Oppose Having a Codex Oversight Hearing, and Ask Why They Don't Enforce Article 14.3 in their Bylaws: (Conflict of Interest)
Ask why they don't kick Warner Lambert and the rest of the drug cartel OUT of NNFA!
Ask Why they endorse the NAS paper "A Risk Assessment Model For Establishing Upper Levels for Nutrients" when it is being used illegally by the FDA to break past the consumer generated impasse at Codex. [See Codex Oversight Section http://www.iahf.com]
**************************************************************